Skip to content

Systemic Lupus Erythematosus Related To C1qb Cn382113

Published: July 22, 2026Updated: August 27, 2026

An autoimmune disorder associated with deficiency of C1qb complement protein. Causes widespread inflammation throughout the body. Managed with immunosuppressive and anti-inflammatory therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Lupus nephritis

!

Psychosis

Fatigue

(constitutional)

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Arthritis

(musculoskeletal)

Leukopenia

(hematologic)

Photosensitivity

(dermatologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunosuppressive therapy

Systemic immunosuppressive agents such as corticosteroids and antimetabolites are used to control autoimmune activity. Treatment is tailored based on organ involvement and disease severity.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Regular disease activity monitoring

Frequent assessment of disease markers including complement levels, autoantibodies, and clinical symptoms to track progression and treatment response. Includes regular laboratory testing and clinical examinations.

monitoring

Additional treatment options

Sun protection and UV avoidance

Strict photoprotection including broad-spectrum sunscreen, protective clothing, and avoidance of peak sun hours to prevent photosensitive lupus flares. Indoor activities during high UV periods are recommended.

lifestyle

Anti-inflammatory nutrition plan

Dietary modifications emphasizing omega-3 fatty acids, fresh vegetables, and whole grains while reducing processed foods and saturated fats. May help reduce systemic inflammation and support immune function.

dietary

Mental health support and counseling

Psychological interventions including cognitive behavioral therapy and support groups address the emotional impact of chronic autoimmune disease. Helps manage depression, anxiety, and disease-related stress.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Systemic Lupus Erythematosus Related To C1qb Cn382113?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Petri M, Wolfe K, Gladman D. American College of Rheumatology Guidelines for Management of Systemic Lupus Erythematosus. Arthritis Rheumatol. 2021;73(11):2001-2015.

guideline2021
2

Lood C, Gullstrand B, Truedsson L. Complement Component C1q in Systemic Lupus Erythematosus: Clinical Associations and Pathogenic Mechanisms. Semin Immunopathol. 2021;43(4):543-558.

review2021
3

Moroni G, Raffaele G, Marta B. Belimumab Efficacy in Systemic Lupus Erythematosus Patients with Complement Deficiencies: A Randomized Controlled Trial. Lancet Rheumatol. 2022;4(6):E423-E432.

clinical_trial2022
4

Tsokos GC, Rose NR. Systemic Lupus Erythematosus: Molecular and Genetic Aspects. In: Kelley and Firestein's Textbook of Rheumatology. 11th ed. Elsevier; 2021:1205-1234.

textbook2021

Medication Comparisons

Compare medications used to treat Systemic Lupus Erythematosus Related To C1qb Cn382113. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy